Compare TKNO & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TKNO | SOPH |
|---|---|---|
| Founded | 1996 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.1M | 367.7M |
| IPO Year | 2021 | 2021 |
| Metric | TKNO | SOPH |
|---|---|---|
| Price | $3.18 | $5.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 120.7K | 92.4K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $40,520,000.00 | N/A |
| Revenue This Year | $8.27 | $23.09 |
| Revenue Next Year | $13.13 | $19.57 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.35 | N/A |
| 52 Week Low | $1.91 | $2.58 |
| 52 Week High | $7.48 | $5.70 |
| Indicator | TKNO | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 63.15 | 58.15 |
| Support Level | $3.01 | $4.54 |
| Resistance Level | $3.22 | $5.31 |
| Average True Range (ATR) | 0.25 | 0.29 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 91.04 | 61.25 |
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.